UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), an oncology company developing innovative, full-length ...
The ASCO Annual Meeting is widely regarded as the largest and most prestigious medical oncology conference in the world, attracting tens of thousands of leading oncologists, researchers, and ...
Accepted abstracts showcase Nexalin’s proprietary DIFS™ 15 mA 77.5 Hz treatment platform and clinical improvements across ...
Prepare a poster as per instructions above In addition, the presenter will have 3 minutes to share the research question(s), a brief overview of the data/methods and key findings in the form of slides ...
Contributions on the topics listed in the Conference Announcement under Section C are welcome as oral or poster presentations. All submissions, apart from invited papers, must present original work, ...
PRT3789, a novel, highly-selective SMARCA2 degrader in patients with advanced solid tumors with a SMARCA4 mutation plenary session presentation: October 24, 2024, 10:00 AM CEST (4:00 AM EST) ...
Pharvaris, a biopharmaceutical company based in Zug, Switzerland, announced that abstracts for multiple presentations have been accepted for the 2025 National Summit of the US Hereditary Angioedema ...
TOPEKA, Kan. (WIBW) - The Governor’s Water Conference will highlight the latest policy and research developments on water issues in Kansas. According to the Kansas Water Office, the 13th annual ...
(MENAFN- GlobeNewsWire - Nasdaq) Accepted abstracts showcase Nexalin's proprietary DIFSTM 15 mA 77.5 Hz treatment platform and clinical improvements across anxiety, depression, insomnia and quality of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results